Scientific & Medical Literature

For Patients For Health Care Professionals For Patients Scientific Evidence: Beta-caryophyllene is a natural terpene that exists in the cannabis and hemp plants as well as in other common plants (eg. Cloves and black pepper).  It is known to work directly on cannabinoid CB2 receptors to help decrease inflammation...

For Patients For Health Care Professionals For Patients Scientific Evidence: CBD and its natural acid form CBDA are known to have effects at the molecular level to help control anxiety by acting and increasing the sensitivity of serotonin 5-HT1A receptors. These receptors play a key role in helping to...

For Patients For Health Care Professionals For Patients Clinical Evidence: There are a number of clinical trials showing reduction of social anxiety disorder and reversal of THC induced anxiety with CBD containing products. CBD is non-sedating and not addictive, unlike many other products used to control anxiety (eg. benzodiazepines...

For Patients For Health Care Professionals For Patients Scientific Evidence: CBD when administered topically has shown to rapidly decrease inflammation in experimental animal models. This reduction in inflammation results in a decrease correlated reduction in pain. Clinical and Scientific Evidence References: Baswan SM et al. Therapeutic Potential of Cannabidiol...

For Patients For Health Care Professionals For Patients Clinical Evidence: There are over 9 randomized controlled clinical trials and 2 open label clinical trials assessing CBD with or without THC for the management of pain and show varying levels of pain relief depending on the cause of pain, doses...

For Patients For Health Care Professionals For Patients Clinical Evidence: CB4 Derma was clinically tested in a limited trial of 4 weeks. The results showed consistent improvement in hydration, reduction in the level of redness as well disappearance of inflamed red skin (erythema) after repeated use. Scientific Evidence: CBD...

For Patients For Health Care Professionals For Patients Scientific Evidence: CBD and its natural acid form CBDA are known to have effects at the molecular level to help control pain anxiety by acting and increasing the sensitivity of serotonin 5 HT1a receptors. These receptors play a key role in...

For Patients For Health Care Professionals For Patients Scientific Evidence: CBD has decrease inflammation of skin cells, decrease signalling of immune cells responsible for inflammation, skin tissue maintenance, and has anti-bacterial properties. All of these effects are desirable in controlling skin conditions such as acne.   Additionally, rosemary essential oil...

For Patients For Health Care Professionals For Patients Clinical Evidence: There are over 9 randomized controlled clinical trials and 2 open label clinical trials assessing CBD with or without THC for the management of pain and show varying levels of pain relief depending on the cause of pain, doses...

For Patients For Health Care Professionals For Patients Clinical Evidence: Versafilm® is a patented sublingual filmstrip technology used in multiple pharmaceutical products in development and on the market for many uses (erectile dysfunction, migraines, mood disorders). Clinical trial with Versafilm® and multiple drugs have shown rapid and more complete...

For Patients For Health Care Professionals For Patients Clinical Evidence: VESIsorb® is a safe and effective drug delivery pharmaceutical technology that can help  dramatically improve the bioavailability of poorly absorbed ingredients such as THC, CBD and terpenes (BCP). A specific clinical trial (among many trials conducted for VESIsorb® products)...

Clinical Evidence: VESIsorb® is a safe and effective drug delivery pharmaceutical technology that can help  dramatically improve the bioavailability of poorly absorbed ingredients such as THC, CBD and terpenes (BCP). A specific clinical trial (among many trials conducted for VESIsorb® products) tested for improvement in BCP absorption and showed...